Patient Note — 240020

progress_notes_240020_1_deid.txt

← Back to all patients Run PA Decision for this patient →

Demographics & Encounter

Patient ID240020 (PHI redacted)
Age / Gender68 / Male
Date of Service2026-04-10
Provider[PROVIDER_NAME]
FacilityPOTOMAC UROLOGY CENTER - Alexandria
PayerMedicare VA
Reason1. Prostate pain

Diagnoses

C61 Malignant neoplasm of prostate
N40.0 Enlarged prostate
S32.592S Other closed fracture of left pubis, sequela
N42.81 Prostatic pain

Medications

Tamsulosin HCl 0.4 MG Capsule 1 cap(s) orally once a day Orgovyx(Relugolix) valACYclovir HCl Medication List reviewed and reconciled with the patient Progress Note: [PROVIDER_NAME], MD 04/10/2026 Note generated by eClinicalWorks EMR/PM Software (www.eClinicalWorks.com) Generated for Printing/Faxing/eTransmitting on: 04/12/2026 04:39 PM EDT 1/4 4/13/26, 2:09 AM Print Preview [PATIENT_NAME] DOB: [DOB] (68 yo M) Acc No. [ACCOUNT_ID] DOS: 04/10/2026

Past Medical History

  • Prostate Cancer

Clinical Summary (HPI)

Prostate Cancer (localized): 68yM patient with gleason 4+3=7 prostate cancer s/p Barrigel/Fiducials (5/27/2025) and XRT (8/11/2025) presents today for FU on 6 month ADT Orgovyx (May'25 to Nov'25) - - - - - - - - - - - - - - The patient's previous work-up history is listed below: TREATMENT: Barrigel/Fiducials XRT (8/11/2025) Orgovyx(May'25-Nov'25) PSA: 7.6 (February 2024 - Verbal), 0.17 (Aug 2025) TESTO: 9 (Aug 2025) Decipher: 0.23; Low-risk (Feb'25) Prostate bx ( Feb 2025):LB 4+3=7 10% tissue, LM 3+3=6 20% tissue, LA 3+4=7 30% tissue, LLB 3+4=7 10% tissue, LLM 3+4=7 20% tissue, LLA 3+3=6 60% tissue, 1A 3+4=7 50% tissue, 1B 3+4=7 50% tissue, 1C 4+3=7 20% tissue pMRI (November 2024): 1. Left apex peripheral zone lesion, PI-RSDS v2.1 category 4. 2. No findings suspicious for tumoral extraprostatic extension or metastatic disease within the imaged pelvis. 3. Prostate volume of 42cc. PI-RADS 4. CT Abd/Pelvis (April 2024): Normal sized kidneys without obstruction. Bilateral simple renal cysts. No suspicious renal cortical mass or urolethial lesion. No evidence of metastatic disease. CMP: GLU 97, BUN 15.6, CREA 1.18, NA 131 L, CL 96 L. (Aug 2025) CBC: WBC 3.6 L, RBC 3.83 L, MONO% 13.1 H, LYMPH% 11.4 L, GRAN% 75.5 H (Aug 2025). BPH screening: with BPH. - - - - - - - - - - - - - - The patient's previous work-up history is listed below: Treatment: Tamsuolosin 0.4 mg.

Raw Note (de-identified preview)

4/13/26, 2:09 AM Print Preview [PATIENT_NAME] DOB: [DOB] (68 yo M) Acc No. [ACCOUNT_ID] DOS: 04/10/2026 [PATIENT_NAME] 68 Y old Male, DOB: [DOB] Account: [ACCOUNT_ID]: [PHONE] [ADDRESS] Home: [PHONE] Guarantor: [GUARANTOR_NAME] Insurance: Medicare VA (Palmetto) PCP: [PROVIDER_NAME] Referring: [PROVIDER_NAME] Appointment Facility: POTOMAC UROLOGY CENTER - Alexandria Structured Data: How did you hear about us? : Other; Patient's temperature : 0 04/10/2026 Progress Notes: [PROVIDER_NAME], MD Reason for Appointment 1. Prostate pain History of Present Illness Prostate Cancer (localized): 68yM patient with gleason 4+3=7 prostate cancer s/p Barrigel/Fiducials (5/27/2025) and XRT (8/11/2025) presents today for FU on 6 month ADT Orgovyx (May'25 to Nov'25) - - - - - - - - - - - - - - The patient's previous work-up history is listed below: TREATMENT: Barrigel/Fiducials XRT (8/11/2025) Orgovyx(May'25-Nov'25) PSA: 7.6 (February 2024 - Verbal), 0.17 (Aug 2025) TESTO: 9 (Aug 2025) Decipher: 0.23; Low-risk (Feb'25) Prostate bx ( Feb 2025):LB 4+3=7 10% tissue, LM 3+3=6 20% tissue, LA 3+4=7 30% tissue, LLB 3+4=7 10% tissue, LLM 3+4=7 20% tissue, LLA 3+3=6 60% tissue, 1A 3+4=7 50% tissue, 1B 3+4=7 50% tissue, 1C 4+3=7 20% tissue pMRI (November 2024): 1. Left apex peripheral zone lesion, PI-RSDS v2.1 category 4. 2. No findings suspicious for tumoral extraprostatic extension or metastatic disease within the imaged pelvis. 3. Prostate volume of 42cc. PI-RADS 4. CT Abd/Pelvis (April 2024): Normal sized kidneys without obstruction. Bilateral simple renal cysts. No suspicious renal cortical mass or urolethial lesion. No evidence of metastatic disease. CMP: GLU 97, BUN 15.6, CREA 1.18, NA 131 L, CL 96 L. (Aug 2025) CBC: WBC 3.6 L, RBC 3.83 L, MONO% 13.1 H, LYMPH% 11.4 L, GRAN% 75.5 H (Aug 2025). BPH screening: with BPH. - - - - - - - - - - - - - - The patient's previous work-up history is listed below: Treatment: Tamsuolosin 0.4 mg. Current Medications Taking Tamsulosin HCl 0.4 MG Capsule 1 cap(s) orally once a day Orgovyx(Relugolix) 120 MG Tablet 1 tab(s) orally once a day Not-Taking valACYclovir HCl 1 GM Tablet Oral Medication List reviewed and reconciled with the patient Progress Note: [PROVIDER_NAME], MD 04/10/2026 Note generated by eClinicalWorks EMR/PM Software (www.eClinicalWorks.com) Generated for Printing/Faxing/eTransmitting on: 04/12/2026 04:39 PM EDT 1/4 4/13/26, 2:09 AM Print Preview [PATIENT_NAME] DOB: [DOB] (68 yo M) Acc No. [ACCOUNT_ID] DOS: 04/10/2026 Past Medical History Prostate Cancer. Surgical History Denies Past Surgical History Family History Father: deceased Mother: deceased Social History Smoking: no Recreational drug use: no. Exercise: no. Caffeine: yes. Sexually active: no. Occupation: no. Tobacco Control (Standard) Tobacco use: Nonsmoker AUDIT-C (Standard) Did you have a drink containing alcohol in the past year? No Points 0 Interpretation Negative Screening Allergies N.K.D.A. Hospitalization/Major Diagnostic Procedure Denies Past Hospitalizat